文献标引:魏鹏，李淑敏.卵巢交界性上皮性肿瘤的诊治进展[J/CD].中华临床医师杂志：电子版,2010,4(3):257-261.

参考文献:
[1]　Hart WR. Borderline epithelial tumors of the ovary. Mod Pathol，2005，18 Suppl 2：S33－S55.[PubMed]
[2]　Allison KH，Swisher EM，Kerkering KM，et al. Defining an appropriate threshold for the diagnosis of serous borderline tumor of the ovary：when is a full staging procedure unnecessary？Int J Gynecol Pathol，2008，27（1）：10－17.[PubMed]
[3]　De Iaco P，Ferrero A，Rosati F，et al. Behaviour of ovarian tumors of low malignant potential treated with conservative surgery. Eur J Surg Oncol，2009，35（6）：643－648.[PubMed]
[4]　Park JY，Kim DY，Kim JH，et al. Surgical management of borderline ovarian tumors：The role of fertility-sparing surgery. Gynecol Oncol，2009，113（1）：75－82.[PubMed]
[5]　糜若然，瞿全新. 卵巢交界性瘤. 中国实用妇科与产科杂志，2003，19（8）：460－462.
[6]　Kokawa K，Mikami Y，Sakata H，et al. Clinical outcome and prognostic factors in borderline tumors of the ovary. Results from 17 years′experience in the Kinki District of Japan （1990-2006）. Eur J Gynaecol Oncol，2009，30（2）：155－161.[PubMed]
[7]　Crispens MA. Borderline ovarian tumours：a review of the recent literature. Curr Opin Obstet Gynecol，2003，15（1）：39－43.[PubMed]
[8]　Ren J，Peng Z，Yang K. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors. Gynecol Oncol，2008，110（2）：162－167.[PubMed]
[9]　Trimble CL，Kosary C，Trimble EL. Long-term survival and patterns of care in women withovarian tumors of low maligant potential. Gynecol Oncol，2002，86（1）：34－37.[PubMed]
[10]　Bell DA，Scully RE. Ovarian serous borderline tumors with stromal microinvasion：a report of 21 cases. Hum Pathol，1990，21（4）：397－403.[PubMed]
[11]　Sieben NL，Kolkman-Uljee SM，Flanagan AM，et al. Molecular genetic evidence for moncclonal origin of bilateral ovarian serous borderline tumors. Am J Pathol，2003，162（4）：1095－1101.[PubMed]
[12]　Mooney J，Silva E，Tornos C，et al. Unusual features of serous neoplasms of low maligant potential during pregancy. Gynecol Oncol，1997，65（1）：30－35.[PubMed]
[13]　Deavers MT，Gershenson DM，Tortolero-Luna G，et al. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential：a study of 99 advanced stage cases. Am J Surg Pathol，2002，26（9）：1129－1141.[PubMed]
[14]　Gershenson DM，Silva EG，Levy L，et al. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer，1998，82（6）：1096－1103.[PubMed]
[15]　郭丽娜，连利娟. 卵巢浆液性交界瘤高危病例的病理特点. 生殖医学杂志，2004，13（3）：179－181.
[16]　Lee KR，Scully RE. Mucinous tumors of the ovary：a clinicopathologic study of 196 borderline tumors （of intestinal type）and carcinomas，including an evaluation of 11 cases with ‘pseudomyxoma peritonei’. Am J Surg Pathol，2000，24（11）：1447－1464.[PubMed]
[17]　Rodríguez IM，Prat J. Mucinous tumors of the ovary：a clinicopathologic analysis of 75 borderline tumors （of intestinal type）and carcinomas. Am J Surg Pathol，2002，26（2）：139－152.[PubMed]
[18]　Nayar R，Siriaunkgul S，Robbins KM，et al. Microinvasion in low malignant potential tumors of the ovary. Hum Pathol，1996，27（6）：521－527.
[19]　Khunamornpong S，Russell P，Dalrymple JC. Proliferating（LMP）mucinous tumors of the ovaries with microinvasion：morphologic assessment of 13 cases. Int J Gynecol Pathol，1999，18（3）：238－246.[PubMed]
[20]　Riopel MA，Ronnett BM，Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors：atypical proliferative（borderline）tumors and intraepithelial，microinvasive，invasive，and metastatic carcinomas. Am J Surg Pathol，1999，23（6）：617－635.[PubMed]
[21]　Nomura K，Aizawa S. Noninvasive，microinvasive，and invasive mucinous carcinomas of the ovary：a clinicopathologic analysis of 40 cases. Cancer，2000，89（7）：1541－1546.[PubMed]
[22]　Kayikçioglu F，Pata O，Cengiz S，et al. Accuracy of frozen section diagnosis in borderline ovarian malignancy. Gynecol Obstet Invest，2000，49（3）：187－189.[PubMed]
[23]　Ayhan A，Guven S，Guven ES，et al. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors？Acta Obstet Gynecol Scand，2007，86（4）：484－490.[PubMed]
[24]　Gotlieb WH，Soriano D，Achiron R. CA 125 measurement and ultrasonography in borderline tumors of the ovary. Am J Obstet Gynecol，2000，183（3）：541－546.[PubMed]
[25]　Buttin BM，Herzog TJ，Powell MA，et al. Epithelial ovarian tumors of low malignant potential：the role of microinvasion. Obstet Gynecol，2002，99（1）：11－17.[PubMed]
[26]　Engelen MJ，de Bruijn HW，Hollema H，et al. Serum CA 125，carcinoembryonic antigen，and CA 19-9 as tumor markers in borderline ovarian tumors. Gynecol Oncol，2000，78（1）：16－20.[PubMed]
[27]　Leake JF，Currie JL，Rosenshein NB，et al. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol，1992，47（1）：150－158.[PubMed]
[28]　Wang J，Luo F，Lu JJ，et al. VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors. Int J Cancer，2002，97（2）：163－167.[PubMed]
[29]　唐军，赖娟，耿京，等. 术前诊断卵巢交界性肿瘤的超声特征. 中国妇产科临床杂志，2007，8（3）：172－184.
[30]　Bent CL，Sahdev A，Rockall AG，et al. MRI appearances of borderline ovarian tumours. Clin Radiol，2009，64（4）：430－438.[PubMed]
[31]　Rose PG，Rubin RB，Nelson BE，et al. Accuracy of frozen-section（intraoperative consultation）diagnosis of ovarian tumors. Am J Obstet Gynecol，1994，171（3）：823－826.[PubMed]
[32]　Houck K，Nikrui N，Duska L，et al. Borderline tumors of the ovary：correlation of frozen and permanent histopathologic diagnosis. Obstet Gynecol，2000，95（6 Pt 1）：839－843.[PubMed]
[33]　Uzan C，Kane A，Rey A，et al. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary. Ann Oncol，2010，21（1）：55－60.[PubMed]
[34]　Michael H，Roth LM. Invasive and noninvasive implants in ovarian serous tumors of low malignant potential. Cancer，1986，57（6）：1240－1247.[PubMed]
[35]　任婕，楼江燕，刘辉，等. 交界性卵巢上皮性肿瘤234例临床病理及预后分析. 中华妇产科杂志，2009，44（2）：116－120.
[36]　Camatte S，Morice P，Atallah D，et al. Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor：an analysis of a series of 42 lymphadenectomies. J Am Coll Surg，2002，195（3）：332－338.[PubMed]
[37]　Fadare O，Orejudos MP，Jain R，et al. A comparative analysis of lymphatic vessel density in ovarian serous tumors of low malignant potential（borderline tumors）with and without lymph node involvement. Int J Gynecol Pathol，2008，27（4）：483－490.
[38]　Sevcík L，Klát J，Koliba P，et al. Radical surgical therapy and role of adjuvant chemotherapy in ovarian tumors of borderline malignancy. Ceska Gynekol，2004，69（6）：488－492.[PubMed]
[39]　Morice P，Camatte S，Rey A，et al. Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Ann Oncol，2003，14（4）：592－598.[PubMed]
[40]　Manchul LA，Simm J，Levin W，et al. Borderline epithelial ovarian tumors：a review of 81 cases with an assessment of the impact of treatment. Int J Radiat Oncol Biol Phys，1992，22（5）：867－874.[PubMed]
[41]　Bell DA，Weinstock MA，Scully RE. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer，1988，62（10）：2212－2222.[PubMed]
[42]　Leake JF，Currie JL，Rosenshein NB，et al. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol，1992，47（2）：150－158.[PubMed]
[43]　Kane A，Uzan C，Rey A，et al. Prognostic factors in patients with ovarian serous low malignant potential（borderline）tumors with peritoneal implants. Oncologist，2009，14（6）：591－600.[PubMed]